[Ovulation inhibitors and tumors].
D001943:Breast Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D008545:Melanoma / Q000139:chemically induced / Q000453:epidemiology; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D010051:Ovarian Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D010060:Ovulation / Q000187:drug effects*; D010911:Pituitary Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D011388:Prolactin / Q000378:metabolism; D012306:Risk; D012878:Skin Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D014594:Uterine Neoplasms / Q000139:chemically induced / Q000453:epidemiology
D003271:Contraceptive Agents, Female; D011388:Prolactin
Ovulationshemmer und Tumoren.